LicianPro

EXELIXIS, INC. ·

EXEL 8-K 2026-09-11

EXELIXIS, INC. (EXEL) 8-K dated 2026-09-11 — accession 0000939767-26-000108.

EXELIXIS, INC. (EXEL) is a biotechnology company listed on US.

EXELIXIS, INC. filed a 8-K on 2026-09-11. Accession 0000939767-26-000108.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported EXEL revenue for 2026-01-02 was $2.32B. Net income was $782.6M. Revenue was up 7.0% from 2025-01-03 to 2026-01-02. EXEL currently screens at market cap $12.69B and trailing P/E 19.7.

Not investment advice. The EXEL SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr